Global Transdermal Drug Delivery System market is projected to reach $10.77 billion by 2032

From GlobeNewswire: 2025-03-04 10:05:00

The global Transdermal Drug Delivery System Market was valued at USD 7.23 billion in 2023 and is projected to reach USD 10.77 billion by 2032, with a CAGR of 4.54% from 2024 to 2032. Advancements in technologies and patient preference for non-invasive drug delivery methods are driving market growth.

Transdermal delivery systems offer sustained and controlled release of drugs, enhancing efficacy and patient compliance. They are increasingly used in pain relief, hormone replacement, and CNS diseases. The market is also fueled by the rising incidence of chronic diseases that require long-term therapy.

Iontophoresis was the most popular technology in the TDDS industry in 2023, with a 19.1% market share. Mechanical arrays, utilizing microneedle technology, are expected to show exponential growth. Pain management was the leading application area in 2023, with hormone therapy projected to be the fastest-growing application.

North America led the TDDS market in 2023, while the Asia-Pacific region is expected to experience the highest growth due to increasing healthcare spending and awareness of advanced drug delivery methods. Recent developments include a recall of Fentanyl patches and promising results from a Phase III trial of a transdermal CGRP inhibitor patch for migraines. Transdermal Drug Delivery System Market Analysis & Outlook 2024-2032 is now available. SNS Insider provides current, accurate market data, consumer insights, and opinions to help clients make informed decisions in changing circumstances. Access the complete report details at https://www.snsinsider.com/reports/transdermal-drug-delivery-system-market-5639. Trust SNS Insider for comprehensive market research and consulting services globally.



Read more at GlobeNewswire: Transdermal Drug Delivery System Market Size to Hit USD